[Treatment with immunoglobulins].
The application of various formulations of immunoglobulins has become feasible for an impressive array of indications, and the number of available preparations is quite considerable. Nevertheless aside from immunologic/haematologic routine the relation of promise, cost and risk is hard to estimate. This presentation will try to review these factors for certain groups of diseases.
Junker
U
U
Institut für Klinische Immunologie, Friedrich-Schiller-Universität Jena. iuj@rz.uni-jena.de
D006801:Humans; D007116:Immunization, Passive / Q000009:adverse effects / Q000191:economics / Q000379:methods; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007153:Immunologic Deficiency Syndromes / Q000628:therapy; D012307:Risk Factors
D016756:Immunoglobulins, Intravenous